Cantor Fitzgerald restated their overweight rating on shares of Molina Healthcare (NYSE:MOH – Free Report) in a research note published on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $406.00 price target on the stock.
A number of other research firms have also issued reports on MOH. JPMorgan Chase & Co. decreased their price objective on Molina Healthcare from $420.00 to $395.00 and set an overweight rating on the stock in a research note on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft decreased their price target on Molina Healthcare from $354.00 to $353.00 and set a hold rating on the stock in a research report on Monday, July 29th. Baird R W upgraded shares of Molina Healthcare to a strong-buy rating in a research report on Thursday, May 30th. Jefferies Financial Group decreased their target price on shares of Molina Healthcare from $354.00 to $297.00 and set a hold rating on the stock in a report on Wednesday, July 24th. Finally, Robert W. Baird assumed coverage on shares of Molina Healthcare in a research note on Thursday, May 30th. They issued an outperform rating and a $405.00 target price on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Molina Healthcare has a consensus rating of Moderate Buy and an average target price of $378.00.
Check Out Our Latest Research Report on Molina Healthcare
Molina Healthcare Price Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, topping the consensus estimate of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The company had revenue of $9.88 billion during the quarter, compared to the consensus estimate of $9.75 billion. During the same period last year, the firm earned $5.65 EPS. Molina Healthcare’s revenue for the quarter was up 18.7% on a year-over-year basis. Equities analysts forecast that Molina Healthcare will post 23.5 EPS for the current year.
Insider Transactions at Molina Healthcare
In other news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the transaction, the director now directly owns 18,025 shares in the company, valued at $6,114,260.25. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.
Hedge Funds Weigh In On Molina Healthcare
Institutional investors and hedge funds have recently made changes to their positions in the business. Innealta Capital LLC bought a new stake in Molina Healthcare in the second quarter worth $36,000. Ashton Thomas Private Wealth LLC bought a new stake in shares of Molina Healthcare in the 2nd quarter valued at about $40,000. Principal Securities Inc. purchased a new stake in Molina Healthcare during the 4th quarter valued at about $42,000. AM Squared Ltd purchased a new stake in Molina Healthcare during the 2nd quarter valued at about $59,000. Finally, Mather Group LLC. bought a new position in Molina Healthcare during the 1st quarter worth approximately $123,000. Institutional investors own 98.50% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More
- Five stocks we like better than Molina Healthcare
- What does consumer price index measure?
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- Compound Interest and Why It Matters When Investing
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.